Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death
- 1 July 2007
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 12 (1), 66-80
- https://doi.org/10.1016/j.ccr.2007.05.006
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Mcl-1 Interacts with Truncated Bid and Inhibits Its Induction of Cytochrome c Release and Its Role in Receptor-mediated ApoptosisJournal of Biological Chemistry, 2006
- Smac/Diablo Antagonizes Ubiquitin Ligase Activity of Inhibitor of Apoptosis ProteinsPublished by Elsevier BV ,2004
- Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear LocalizationJournal of Biological Chemistry, 2003
- DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cellsGenes & Development, 2003
- Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomainCell Death & Differentiation, 2002
- Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic ApproachJournal of Biological Chemistry, 2001
- Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical CaspasesPublished by Elsevier BV ,2001
- Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors Signal NF-κB and JNK Activation and Apoptosis through Distinct PathwaysJournal of Biological Chemistry, 1999
- Inhibition of death receptor signals by cellular FLIPNature, 1997
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992